About the Company
PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with aspirin and ibuprofen, and potentially other drugs.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PLXP News
PLx Pharma Inc. Common Stock (PLXP)
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Why Is PLx Pharma (PLXP) Stock Down 32% Today?
PLx Pharma (NASDAQ:PLXP) stock continues to fall on Wednesday as the company gets closer to being delisted from the Nasdaq. An update from PLx Pharma revealed that the Nasdaq is not giving it ...
PLX Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx ...
PLX Inc
PLX Inc. is a state-of-the-art optical solutions provider and the leader in development and fabrication of monolithic and invariant optics, and the pioneers of hollow retroreflectors, such as the ...
Robert G. Shawah's Net Worth
This is based on reported shares across multiple companies, which include PLx Pharma Inc., AMERI Holdings, Inc., and Acurx Pharmaceuticals, Inc..
Baseball Legend John Smoltz Featured on PLx Pharma’s Social Channels
PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard ...
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript March 14, 2024 Protalix BioTherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations ...
Cocrystal Pharma Stock (NASDAQ:COCP), Quotes and News Summary
Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday. Lisa Levin $2M Bet On Cocrystal Pharma?
HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company’s ...
Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...
Protalix BioTherapeutics, Inc. (PLX)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript March 14, 2024 Protalix BioTherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were ...
Loading the latest forecasts...